Related Experiment Video
Updated: Aug 12, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
Live-attenuated varicella vaccine
1Department of Pediatrics, Columbia University College of Physicians & Surgeons, New York, New York, USA. aag1@columbia.edu
Abstract:
This article reviews the history and development of live attenuated varicella vaccine from its early days in Japan to its widespread use throughout the world. The vaccine has proven extremely safe after immunization of as many as 10 million healthy children and adults in the United States alone. The vaccine is also highly immunogenic and offers close to 100% protection from severe chickenpox and 90% protection from illness. It is expected to have a major impact on the epidemiology of varicella and zoster in countries with high vaccine uptake.
Related Concept Videos
Vaccinations
Vaccines
Smallpox
Chickenpox
Poliomyelitis
Respiratory Syncytial Virus Disease

